272 related articles for article (PubMed ID: 20821211)
1. Transcatheter arterial chemoembolization with epirubicin-loaded superabsorbent polymer microspheres for 135 hepatocellular carcinoma patients: single-center experience.
Seki A; Hori S; Kobayashi K; Narumiya S
Cardiovasc Intervent Radiol; 2011 Jun; 34(3):557-65. PubMed ID: 20821211
[TBL] [Abstract][Full Text] [Related]
2. Switching the loaded agent from epirubicin to cisplatin: salvage transcatheter arterial chemoembolization with drug-eluting microspheres for unresectable hepatocellular carcinoma.
Seki A; Hori S
Cardiovasc Intervent Radiol; 2012 Jun; 35(3):555-62. PubMed ID: 21562932
[TBL] [Abstract][Full Text] [Related]
3. [Transhepatic arterial chemoembolization by epirubicin mixed with microspheres for hepatocellular carcinoma].
Luo JJ; Yan ZP; Wang JH; Liu QX; Chen Y
Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):619-22. PubMed ID: 18210885
[TBL] [Abstract][Full Text] [Related]
4. Transcatheter arterial chemoembolization with doxorubicin-eluting superabsorbent polymer microspheres in the treatment of hepatocellular carcinoma: midterm follow-up.
Dekervel J; van Malenstein H; Vandecaveye V; Nevens F; van Pelt J; Heye S; Laleman W; Van Steenbergen W; Vaninbroukx J; Verslype C; Maleux G
J Vasc Interv Radiol; 2014 Feb; 25(2):248-55.e1. PubMed ID: 24295569
[TBL] [Abstract][Full Text] [Related]
5. Previous chemoembolization response after transcatheter arterial chemoembolization (TACE) can predict the anti-tumor effect of subsequent TACE with miriplatin in patients with recurrent hepatocellular carcinoma.
Imai N; Ikeda K; Seko Y; Kawamura Y; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Saitoh S; Suzuki F; Suzuki Y; Arase Y; Kumada H
Oncology; 2011; 80(3-4):188-94. PubMed ID: 21709428
[TBL] [Abstract][Full Text] [Related]
6. Transcatheter arterial chemoembolisation for hepatocellular carcinoma in cirrhosis: survival rate and prognostic factors.
Olivo M; Valenza F; Buccellato A; Scala L; Virdone R; Sciarrino E; Di Piazza S; Marrone C; Orlando A; Fusco G; Madonia S; Cottone M
Dig Liver Dis; 2010 Jul; 42(7):515-9. PubMed ID: 19914153
[TBL] [Abstract][Full Text] [Related]
7. Balloon-Occluded Transcatheter Arterial Chemoembolization (b-TACE) for Hepatocellular Carcinoma Performed with Polyethylene-Glycol Epirubicin-Loaded Drug-Eluting Embolics: Safety and Preliminary Results.
Lucatelli P; Ginnani Corradini L; De Rubeis G; Rocco B; Basilico F; Cannavale A; Nardis PG; Corona M; Saba L; Catalano C; Bezzi M
Cardiovasc Intervent Radiol; 2019 Jun; 42(6):853-862. PubMed ID: 30843093
[TBL] [Abstract][Full Text] [Related]
8. [Transcatheter arterial chemoembolization with doxorubicin eluting beads in the treatment of hepatocellular carcinoma].
Sousa PF; Preto AS; Leão D; Madureira AM; Paquete J; Costa-Maia J; Vilares-Morgado P
Acta Med Port; 2011; 24(1):29-36. PubMed ID: 21672439
[TBL] [Abstract][Full Text] [Related]
9. Prospective and randomized trial of lipiodol-transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma: a comparison of epirubicin and doxorubicin (second cooperative study). The Cooperative Study Group for Liver Cancer Treatment of Japan.
Kawai S; Tani M; Okamura J; Ogawa M; Ohashi Y; Monden M; Hayashi S; Inoue J; Kawarada Y; Kusano M; Kubo Y; Kuroda C; Sakata Y; Shimamura Y; Jinno K; Takahashi A; Takayasu K; Tamura K; Nagasue N; Nakanishi Y; Makino M; Masuzawa M; Yumoto Y; Mori T; Oda T
Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-38-S6-45. PubMed ID: 9151915
[TBL] [Abstract][Full Text] [Related]
10. Transcatheter arterial chemoembolization for hepatocellular carcinoma fed by the reconstructed inferior phrenic artery: anatomical and technical analysis.
Miyayama S; Matsui O; Taki K; Minami T; Ito C; Shinmura R; Takamatsu S; Kobayashi M; Notsumata K; Toya D; Tanaka N; Kozaka K
J Vasc Interv Radiol; 2004 Aug; 15(8):815-23. PubMed ID: 15297585
[TBL] [Abstract][Full Text] [Related]
11. Combination of transcatheter arterial embolization and percutaneous ethanol injection for hepatocellular carcinoma: comparison of efficacies of doxorubicin and epirubicin in transcatheter arterial embolization.
Nakamura S; Tanaka K
Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-46-S6-49. PubMed ID: 9151916
[TBL] [Abstract][Full Text] [Related]
12. [Strategy for advanced hepatocellular carcinoma unresponsive to transcatheter arterial chemoembolization using epirubicin].
Kawamura Y; Ikeda K; Kumada H
Gan To Kagaku Ryoho; 2010 Mar; 37(3):402-7. PubMed ID: 20332675
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for the leakage of chemotherapeutic agents into systemic circulation after transcatheter arterial chemoembolization of hepatocellular carcinoma.
Hsieh MY; Lin ZY; Chen SH; Chuang WL
Kaohsiung J Med Sci; 2011 Oct; 27(10):431-6. PubMed ID: 21943814
[TBL] [Abstract][Full Text] [Related]
14. Transcatheter arterial chemoembolization through collateral arteries for hepatocellular carcinoma after arterial occlusion.
Shibata T; Kojima N; Tabuchi T; Itoh K; Konishi J
Radiat Med; 1998; 16(4):251-6. PubMed ID: 9814419
[TBL] [Abstract][Full Text] [Related]
15. Pilot study of transcatheter arterial chemoembolization with degradable starch microspheres in patients with hepatocellular carcinoma.
Furuse J; Ishii H; Satake M; Onaya H; Nose H; Mikami S; Sakai H; Mera K; Maru Y; Yoshino M
Am J Clin Oncol; 2003 Apr; 26(2):159-64. PubMed ID: 12714888
[TBL] [Abstract][Full Text] [Related]
16. Arterial chemoembolization/embolization and early complications after hepatocellular carcinoma treatment: a safe standardized protocol in selected patients with Child class A and B cirrhosis.
Pietrosi G; Miraglia R; Luca A; Vizzini GB; Fili' D; Riccardo V; D'Antoni A; Petridis I; Maruzzelli L; Biondo D; Gridelli B
J Vasc Interv Radiol; 2009 Jul; 20(7):896-902. PubMed ID: 19497762
[TBL] [Abstract][Full Text] [Related]
17. Development of a safety index of transarterial chemoembolization for hepatocellular carcinoma to prevent acute liver damage.
Hwang JI; Chow WK; Hung SW; Li TC; Cheng YP; Ho YJ; Lin CC
Anticancer Res; 2005; 25(3c):2551-4. PubMed ID: 16080491
[TBL] [Abstract][Full Text] [Related]
18. Oily chemoembolization combined with degradable starch microspheres for HCC with cirrhosis.
Murata S; Tajima H; Ichikawa K; Onozawa S; Wang J; Kumita S; Nomura K
Hepatogastroenterology; 2008; 55(84):1041-6. PubMed ID: 18705325
[TBL] [Abstract][Full Text] [Related]
19. [Transarterial chemoembolization (TAE) with degradable starch microspheres (DSM) in advanced hepatocellular carcinoma].
Horikiri N; Yamakado K; Nakatsuka A; Ishii T; Matsushima N; Tanaka N; Takeda K
Gan To Kagaku Ryoho; 2001 Oct; 28(11):1493-6. PubMed ID: 11707962
[TBL] [Abstract][Full Text] [Related]
20. A comparative study of damage to liver function after TACE with use of low-dose versus conventional-dose of anticancer drugs in hepatocellular carcinoma.
Lu W; Li YH; Yu ZJ; He XF; Chen Y; Zhao JB; Zhu ZY
Hepatogastroenterology; 2007; 54(77):1499-502. PubMed ID: 17708284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]